Advocating for Transparency and Oversight in Pain Management
Introduction:
- Welcome back to Painexam, where we delve into the latest advancements and challenges in pain management.
- Today's episode highlights a significant advocacy effort made by leading Interventional Pain Physicians and industry experts.
Summary of Lobbying Effort:
- On March 20, 2024, a group of esteemed physicians and industry leaders, including Drs. Sean Li, Peter Staats, Mehul J. Desai, David Reece, Hemant Kalia, and David Rosenblum, alongside industry figures Mark Stultz, Christopher Conrad, and Cecelia Ruble, visited Capitol Hill to advocate for greater oversight and transparency in independent review organizations.
- Despite their busy schedules, they recognized the critical need to address the 0% turnover rate in appeals for denied treatments, which disproportionately affects patients seeking alternatives to surgery and opioid medication.
Importance of Transparency:
For Board Prep, Ultrasound Training and more, visit:
Dr. David Rosenblum, a pioneer in interventional pain medicine, particularly in ultrasound-
guided procedures and regenerative pain medicine, underscores the necessity of addressing these issues for the benefit of countless patients suffering from chronic pain.
Conclusion and Actionable Steps:
- To schedule a consultation with Dr. Rosenblum, patients can visit www.AABPpain.com or contact the Brooklyn Office at 718-436-7246 or the Garden City Office at 516-482-7246.
- Stay tuned for more updates on advancements and advocacy efforts in pain management.
Outro:
- Thank you for joining us on this episode of Painexam. Be sure to subscribe for future discussions on navigating the complexities of pain management.